Literature DB >> 17452840

The use of bioimpedance analysis to evaluate lymphedema.

Anne G Warren1, Brian A Janz, Sumner A Slavin, Loren J Borud.   

Abstract

BACKGROUND: Lymphedema, a chronic disfiguring condition resulting from lymphatic dysfunction or disruption, can be difficult to accurately diagnose and manage. Of particular challenge is identifying the presence of clinically significant limb swelling through simple and noninvasive methods. Many historical and currently used techniques for documenting differences in limb volume, including volume displacement and circumferential measurements, have proven difficult and unreliable. Bioimpedance spectroscopy analysis, a technology that uses resistance to electrical current in comparing the composition of fluid compartments within the body, has been considered as a cost-effective and reproducible alternative for evaluating patients with suspected lymphedema. PATIENTS AND METHODS: All patients were recruited through the Beth Israel Deaconess Medical Center Lymphedema Clinic. A total of 15 patients (mean age: 55.2 years) with upper-extremity or lower-extremity lymphedema as documented by lymphoscintigraphy underwent bioimpedance spectroscopy analysis using an Impedimed SFB7 device. Seven healthy medical students and surgical residents (mean age: 26.9 years) were selected to serve as normal controls. All study participants underwent analysis of both limbs, which allowed participants to act as their own controls. The multifrequency bioimpedance device documented impedance values for each limb, with lower values correlating with higher levels of accumulated protein-rich edematous fluid.
RESULTS: The average ratio of impedance to current flow of the affected limb to the unaffected limb in lymphedema patients was 0.9 (range: 0.67 to 1.01). In the control group, the average impedance ratio of the participant's dominant limb to their nondominant limb was 0.99 (range: 0.95 to 1.02) (P = 0.01).
CONCLUSIONS: Bioimpedance spectroscopy can be used as a reliable and accurate tool for documenting the presence of lymphedema in patients with either upper- or lower-extremity swelling. Measurement with the device is quick and simple and results are reproducible among patients. Given significant limitations with other methods of evaluating lymphedema, the use of bioimpedance analysis may aid in the diagnosis of lymphedema and allow for tracking patients over time as they proceed with treatment of their disease.

Entities:  

Mesh:

Year:  2007        PMID: 17452840     DOI: 10.1097/01.sap.0000244977.84130.cf

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  20 in total

1.  Risk Factors for Arm Lymphedema in a Cohort of Breast Cancer Patients Followed up for 10 Years.

Authors:  René Aloisio da Costa Vieira; Allini Mafra da Costa; Josue Lopes de Souza; Rafael Richieri Coelho; Cleyton Zanardo de Oliveira; Almir José Sarri; Renato José Affonso Junior; Gustavo Zucca-Matthes
Journal:  Breast Care (Basel)       Date:  2015-12-14       Impact factor: 2.860

2.  Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve.

Authors:  Betty J Smoot; Josephine F Wong; Marylin J Dodd
Journal:  Arch Phys Med Rehabil       Date:  2011-04       Impact factor: 3.966

3.  Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment.

Authors:  Betty Smoot; Sarah Zerzan; Joanne Krasnoff; Josephine Wong; Maria Cho; Marylin Dodd
Journal:  Breast Cancer Res Treat       Date:  2014-10-22       Impact factor: 4.872

Review 4.  Lower extremity lymphedema in patients with gynecologic malignancies.

Authors:  Kimberly Dessources; Emeline Aviki; Mario M Leitao
Journal:  Int J Gynecol Cancer       Date:  2020-01-07       Impact factor: 3.437

5.  Standardized method for quantification of developing lymphedema in patients treated for breast cancer.

Authors:  Marek Ancukiewicz; Tara A Russell; Jean Otoole; Michelle Specht; Marybeth Singer; Alexandra Kelada; Colleen D Murphy; Jessica Pogachar; Valeria Gioioso; Megha Patel; Melissa Skolny; Barbara L Smith; Alphonse G Taghian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-03       Impact factor: 7.038

6.  Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors.

Authors:  Seung Yun Yim; Eunjung Ryu; Jae-Young Lim; Eun Joo Yang; Seung-Min Lee
Journal:  Support Care Cancer       Date:  2015-01-11       Impact factor: 3.603

7.  Risk of secondary lymphedema in breast cancer survivors is related to serum phospholipid fatty acid desaturation.

Authors:  Eunjung Ryu; Seung Yun Yim; Hyun Ju Do; Jae-Young Lim; Eun Joo Yang; Min-Jeong Shin; Seung-Min Lee
Journal:  Support Care Cancer       Date:  2016-04-04       Impact factor: 3.603

8.  Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema.

Authors:  Paula M C Donahue; Rachelle Crescenzi; Chelsea Lee; Maria Garza; Niral J Patel; Kalen J Petersen; Manus J Donahue
Journal:  Breast Cancer Res Treat       Date:  2020-06-29       Impact factor: 4.872

9.  Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema.

Authors:  Shirin M Shallwani; Anna Towers; Anne Newman; Shannon Salvador; Angela Yung; Lucy Gilbert; Walter H Gotlieb; Xing Zeng; Doneal Thomas
Journal:  Curr Oncol       Date:  2021-01-13       Impact factor: 3.677

10.  Pilot study: rapidly cycling hypobaric pressure improves pain after 5 days in adiposis dolorosa.

Authors:  Karen L Herbst; Thomas Rutledge
Journal:  J Pain Res       Date:  2010-08-20       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.